Skip to content

Source filing unavailable

Q2 2010 · —
Revenue$64.57Mno prior Q2 2009 on file+26.9% vs Q1 2010
Net Income$33.20Mno prior Q2 2009 on file+52.1% vs Q1 2010
EPS Diluted$0.71no prior Q2 2009 on file+47.9% vs Q1 2010
Gross Profit$60,094,000—
Operating Income$10,582,000—
Margins · derived
Gross margin93.1%
Operating margin16.4%
Net margin51.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR